Point-of-care testing, with the advances in technology and connectivity in the last 20 years, has become a prominent laboratory service. Point-of-care testing can significantly improve laboratory turn-around times by shortening pre- and post-analytical times. Point-of-care testing can offer easier access for patients at remote locations and other off-site areas. Point-of-care testing requires an inter-disciplinary effort to ensure that quality results are obtained. Cost-effectiveness of point-of-care testing can be realised under controlled conditions.
Point-of-care testing can be a tremendous asset to many types of healthcare providers and healthcare settings. Critical to having a successful POCT program is to ensure quality practices are in place and are faithfully followed. Poor training, improper care of equipment, and lack of quality control is detrimental to the program. The best programs are based on inter-disciplinary team work with the laboratory taking a lead role in managing the program. Each site that provides patient care must carefully evaluate the need for POCT, the equipment to be used, and the personnel performing the tests to ensure accurate and useful data are generated.
The global pandemic of Coronavirus (COVID-19) has triggered stock market instability, tight border controls, and worldwide lockdown, leading the healthcare industry, as well as large companies and governments, to restock supply chains. The whole world is experiencing severe impact on social and financial sectors, and all global industries are facing challenges during the COVID-19 pandemic. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
The global market is studied for the key regions such as, North America, Europe, Asia Pacific and Rest of the World. North America comprises of U.S., Canada and Mexico. Whereas, Europe covers UK, France, Germany, Italy, Spain and Rest of Europe. The key countries included under Asia Pacific are China, India, Japan and Rest of Asia Pacific. The Rest of the world include Latin America and Middle East & Africa. North America was a lucrative region for the Cloud-based point of care informatics market in 2019. The market growth is due to factors such as the presence of a high prevalence of cancer and cardiovascular disease patients in the region, established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.
Various product type considered in the market are cardiometabolic monitoring products, cholesterol testing products, coagulation monitoring products, drugs-of-abuse testing products, fecal occult testing products, glucose monitoring products, hematology testing products, infectious disease testing products, pregnancy & fertility testing products, tumor/cancer marker testing products, urinalysis testing products and others. Various component studied are services and software. The end users of the market is segmented into clinical laboratories and outpatient healthcare & ambulatory care settings, hospitals/critical care centers and others.
The key companies in the Cloud-based point of care informatics market are Abbott Informatics (U.S.), Becton Dickinson and Company (U.S.), Chembio Diganostics (U.S.), Danaher Corporation (U.S.), Orchard Software Corporation (U.S.), Esaote SPA (Italy), Thermo Fisher Scientific (U.S.), Seksui Diagnostics (U.S.), Siemens Healthineers Group (Germay), Seaward Electronic (UK), Hedera Biomedics Srl (Italy), a Hoffman La Roche was Ltd (Switzerland), Autoscribe Limited (U.S.)and Randox Laboratories Ltd (UK).
The report analyses the global cloud-based point of care informatics market based on product type, component, end user and geography. Various product type considered in the market are cardiometabolic monitoring products, cholesterol testing products, coagulation monitoring products, drugs-of-abuse testing products, fecal occult testing products, glucose monitoring products, hematology testing products, infectious disease testing products, pregnancy & fertility testing products, tumor/cancer marker testing products, urinalysis testing products and others. Various component studied are services and software. The end users of the market is segmented into clinical laboratories and outpatient healthcare & ambulatory care settings, hospitals/critical care centers and others.
The global point of care informatics market is studied across various key countries of regions such as, North America, Europe, Asia Pacific and Rest of the World.
Why to buy this report: